These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 30935219)

  • 1. Cost-effectiveness and screening performance of ECG handheld machine in a population screening programme: The Belgian Heart Rhythm Week screening programme.
    Proietti M; Farcomeni A; Goethals P; Scavee C; Vijgen J; Blankoff I; Vandekerckhove Y; Lip GY; Mairesse GH;
    Eur J Prev Cardiol; 2019 Jun; 26(9):964-972. PubMed ID: 30935219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of screening for atrial fibrillation in primary care with a handheld, single-lead electrocardiogram device in the Netherlands.
    Jacobs MS; Kaasenbrood F; Postma MJ; van Hulst M; Tieleman RG
    Europace; 2018 Jan; 20(1):12-18. PubMed ID: 27733465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of mass screening for untreated atrial fibrillation using intermittent ECG recording.
    Aronsson M; Svennberg E; Rosenqvist M; Engdahl J; Al-Khalili F; Friberg L; Frykman-Kull V; Levin LÅ
    Europace; 2015 Jul; 17(7):1023-9. PubMed ID: 25868469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A population screening programme for atrial fibrillation: a report from the Belgian Heart Rhythm Week screening programme.
    Proietti M; Mairesse GH; Goethals P; Scavee C; Vijgen J; Blankoff I; Vandekerckhove Y; Lip GY;
    Europace; 2016 Dec; 18(12):1779-1786. PubMed ID: 27170000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of handheld electrocardiogram devices to detect atrial fibrillation in a cardiology and geriatric ward setting.
    Desteghe L; Raymaekers Z; Lutin M; Vijgen J; Dilling-Boer D; Koopman P; Schurmans J; Vanduynhoven P; Dendale P; Heidbuchel H
    Europace; 2017 Jan; 19(1):29-39. PubMed ID: 26893496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lead-I ECG for detecting atrial fibrillation in patients with an irregular pulse using single time point testing: a systematic review and economic evaluation.
    Duarte R; Stainthorpe A; Greenhalgh J; Richardson M; Nevitt S; Mahon J; Kotas E; Boland A; Thom H; Marshall T; Hall M; Takwoingi Y
    Health Technol Assess; 2020 Jan; 24(3):1-164. PubMed ID: 31933471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cost-effectiveness analysis of screening for silent atrial fibrillation after ischaemic stroke.
    Levin LÅ; Husberg M; Sobocinski PD; Kull VF; Friberg L; Rosenqvist M; Davidson T
    Europace; 2015 Feb; 17(2):207-14. PubMed ID: 25349228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study.
    Hobbs FD; Fitzmaurice DA; Mant J; Murray E; Jowett S; Bryan S; Raftery J; Davies M; Lip G
    Health Technol Assess; 2005 Oct; 9(40):iii-iv, ix-x, 1-74. PubMed ID: 16202350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of a community-based screening programme for chronic atrial fibrillation in Japan.
    Maeda K; Shimbo T; Fukui T
    J Med Screen; 2004; 11(2):97-102. PubMed ID: 15153326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is Screening for Atrial Fibrillation in Canadian Family Practices Cost-Effective in Patients 65 Years and Older?
    Tarride JE; Quinn FR; Blackhouse G; Sandhu RK; Burke N; Gladstone DJ; Ivers NM; Dolovich L; Thornton A; Nakamya J; Ramasundarahettige C; Frydrych PA; Henein S; Ng K; Congdon V; Birtwhistle RV; Ward R; Healey JS
    Can J Cardiol; 2018 Nov; 34(11):1522-1525. PubMed ID: 30144961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-Effectiveness of Extended and One-Time Screening Versus No Screening for Non-Valvular Atrial Fibrillation in the USA.
    Oguz M; Lanitis T; Li X; Wygant G; Singer DE; Friend K; Hlavacek P; Nikolaou A; Mattke S
    Appl Health Econ Health Policy; 2020 Aug; 18(4):533-545. PubMed ID: 31849021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of dabigatran versus vitamin K antagonists for the prevention of stroke in patients with atrial fibrillation: a French payer perspective.
    Chevalier J; Delaitre O; Hammès F; de Pouvourville G
    Arch Cardiovasc Dis; 2014; 107(6-7):381-90. PubMed ID: 24973113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lead-I ECG for detecting atrial fibrillation in patients attending primary care with an irregular pulse using single-time point testing: A systematic review and economic evaluation.
    Duarte R; Stainthorpe A; Mahon J; Greenhalgh J; Richardson M; Nevitt S; Kotas E; Boland A; Thom H; Marshall T; Hall M; Takwoingi Y
    PLoS One; 2019; 14(12):e0226671. PubMed ID: 31869370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Designing an optimal screening program for unknown atrial fibrillation: a cost-effectiveness analysis.
    Aronsson M; Svennberg E; Rosenqvist M; Engdahl J; Al-Khalili F; Friberg L; Frykman V; Levin LÅ
    Europace; 2017 Oct; 19(10):1650-1656. PubMed ID: 28340009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of Remote Heart Rhythm Sampling Using the AliveCor Heart Monitor to Screen for Atrial Fibrillation: The REHEARSE-AF Study.
    Halcox JPJ; Wareham K; Cardew A; Gilmore M; Barry JP; Phillips C; Gravenor MB
    Circulation; 2017 Nov; 136(19):1784-1794. PubMed ID: 28851729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-Effectiveness of a National Opportunistic Screening Program for Atrial Fibrillation in Ireland.
    Moran PS; Teljeur C; Harrington P; Smith SM; Smyth B; Harbison J; Normand C; Ryan M
    Value Health; 2016 Dec; 19(8):985-995. PubMed ID: 27987649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility and cost-effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmacies. The SEARCH-AF study.
    Lowres N; Neubeck L; Salkeld G; Krass I; McLachlan AJ; Redfern J; Bennett AA; Briffa T; Bauman A; Martinez C; Wallenhorst C; Lau JK; Brieger DB; Sy RW; Freedman SB
    Thromb Haemost; 2014 Jun; 111(6):1167-76. PubMed ID: 24687081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of an insertable cardiac monitor to detect atrial fibrillation in patients with cryptogenic stroke.
    Diamantopoulos A; Sawyer LM; Lip GY; Witte KK; Reynolds MR; Fauchier L; Thijs V; Brown B; Quiroz Angulo ME; Diener HC
    Int J Stroke; 2016 Apr; 11(3):302-12. PubMed ID: 26763916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic review and cost-effectiveness evaluation of 'pill-in-the-pocket' strategy for paroxysmal atrial fibrillation compared to episodic in-hospital treatment or continuous antiarrhythmic drug therapy.
    Saborido CM; Hockenhull J; Bagust A; Boland A; Dickson R; Todd D
    Health Technol Assess; 2010 Jun; 14(31):iii-iv, 1-75. PubMed ID: 20569652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of rate control versus rhythm control for management of atrial fibrillation in patients with coexisting heart failure: a cost-effectiveness analysis.
    Perez A; Touchette DR; DiDomenico RJ; Stamos TD; Walton SM
    Pharmacotherapy; 2011 Jun; 31(6):552-65. PubMed ID: 21923439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.